November 19, 2025 — Leads & Copy —
Zoetis Inc. (NYSE:ZTS) will host an Innovation Webcast on Tuesday, December 2, 2025, at 8:30 a.m. ET. The webcast will feature CEO Kristin Peck, Executive Vice President and Chief Financial Officer Wetteny Joseph, Executive Vice President and President of Research and Development Rob Polzer, Ph.D., and Senior Vice President of Global Therapeutics Kevin Esch, D.V.M, M.P.H., Ph.D., Dipl. ACVP (anatomic).
The company will provide updates related to its pipeline, and details about its strategic approach to addressing unmet medical needs for animals, industry-leading R&D capabilities and potential for long-term growth. The webcast will be followed by a Q&A session.
According to the press release, Dr. Esch will succeed Dr. Polzer, effective January 1, 2026, as previously announced.
Investors and the public may access the live webcast and corresponding slides by visiting the Zoetis website. Pre-registration for the webcast is available beginning today. A replay of the webcast will be made available after the event.
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture the world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers.
The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
Source: Zoetis
